Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
QTRX · against 145 other Healthcare companies of similar size
Ranked #98 of 146 · scores higher than 7% of peers
Bars: peers in each 10-point band of the valuation score49 peers with a valuation score of 0–9, including QTRX · Click a bar to see the companies
Mainly because of its earnings yield, EBITDA yield and free cash flow yield, which are weaker than most Healthcare peers.
| Metric | QTRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 130 reported | -89.1% | -11.5% | 13% | 30% | |
| EBITDA yieldHigher is better · 153 reported | -91.6% | 1.5% | 16% | 50% | |
| Free cash flow yieldHigher is better · 102 reported | -58.7% | -16.3% | 19% | 20% | |
| Book yieldHigher is better · 133 reported | 171.2% | 72.2% | 89% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 834M HKD (≈$107M) | 99 | 57 | |
| 1 | 1.4B HKD (≈$181M) | 99 | 61 | |
| 1 | 29.0B JPY (≈$197M) | 99 | 56 | |
| 1 | 592M ILS (≈$160M) | 99 | 84 | |
| 98 | 253M USD | 8 | 15 | |
| 98 | 107M USD | 8 | 26 | |
| 98 | 124M USD | 8 | 31 | |
| 98 | 170M USD | 8 | 35 | |
| 98 | 139M USD | 8 | 32 | |
| 98 | 223M USD | 8 | 34 | |
| 98 | 172M USD | 8 | 34 | |
| 98 | 227M USD | 8 | 24 | |
| 98 | 113M USD | 8 | 23 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score